This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
The global MRI market is currently experiencing steady growth (mid-single digit growth rate). Although economic uncertainty and budgetary constraints have slowed down the market in certain countries, technological innovation and extended/new clinical applications of MRI due to their high importance in the imaging space have enabled it to overcome t...
$4,950.00 -
The latest Medical and Diagnostic Imaging TOE profiles innovations in the imaging space from the Asia-Pacific region. This issue present eight innovative medical imaging technologies and products that stand out in design or application, with a focus on the value offering for emerging countries in Asia. Medical and Diagnostic Imaging TechVision Op...
$950.00 -
24 Jun 2016 | Global
Personal Genomics across the Indian Landscape - Genetic Technology TOE
This edition of the Genetic Technology TOE depicts a range of innovations across personalized genomics specifically across the Indian subcontinent. It provides an overview of some of the major strategic alliances that are happening in India. The companies profiled in this issues, are the current key participants in the personalized genomics space. ...
$250.00 -
The latest edition of Inside R&D TOE profiles innovations across a variety of technology domains. Predominantly, these technologies are in the pre-commercialization phase, or have just been approved for the market. This edition showcases a diagnostic method for the detection of concussions, a novel cancer immunotherapy vaccine, and technologies for...
$250.00 -
24 Jun 2016 | Europe
Business Analytics in Life Sciences
The Time is Ripe for a Technology Revamp in Clinical Trials
The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in ...
$3,000.00 -
23 Jun 2016 | North America
Healthcare Wearables—5 Strategies to Avoid in Development
With regards to wearables and healthcare, strong customer demand and surging sales are only part of the story. The other side of the narrative captures the tale of a highly volatile marketplace where, due to intense competition, there is a revolving door of company entries and exits. Accordingly, Frost & Sullivan’s team, through its tracking of w...
$1,500.00 -
23 Jun 2016 | North America
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00 -
17 Jun 2016 | Global
Medical Technology Innovations in South Korea - Medical Device TOE
This edition of the Medical Device TOE depicts the current landscape and the new trends across South Korea. The study is focused on identifying innovative technology developments within the South Korean medical device industry. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances...
$950.00 -
17 Jun 2016 | Global
Recently Approved Monoclonal Antibodies - Genetic Technology TOE
This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across recently approved monoclonal antibodies. The corresponding patent scenario and industry interactions are also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an...
$250.00 -
13 Jun 2016 | North America
Top Trends in Telehealth from ATA 2016
Strong Growth Opportunities amidst the Undertow of Controversy
The American Telemedicine Association held its annual conference in Minneapolis from May 14 to 17, 2016. This event has become the premier gathering for healthcare professionals, technology innovators, and journalists to attend presentations of key opinion leaders and see the latest telemedicine products on display in an exhibit hall. The highlig...
$1,500.00
